|
EP2963028B1
(en)
|
2009-05-27 |
2018-08-01 |
Atir Holding S.A. |
Piperazine derivatives and their pharmaceutical use
|
|
KR101178181B1
(ko)
*
|
2010-09-17 |
2012-09-19 |
대한민국(농촌진흥청장) |
신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물
|
|
WO2012049555A1
(en)
|
2010-10-13 |
2012-04-19 |
Lupin Limited |
Spirocyclic compounds as voltage-gated sodium channel modulators
|
|
EA201490210A1
(ru)
*
|
2011-07-06 |
2014-05-30 |
Глэксо Груп Лимитед |
Блокаторы потенциалзависимых натриевых каналов
|
|
ES2586213T3
(es)
*
|
2011-10-31 |
2016-10-13 |
Xenon Pharmaceuticals Inc. |
Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
|
|
MX2014005304A
(es)
*
|
2011-10-31 |
2015-03-20 |
Xenon Pharmaceuticals Inc |
Biaril eter sulfonamidas y su uso como agentes terapeuticos.
|
|
US9012450B2
(en)
|
2011-12-28 |
2015-04-21 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
PL2797416T3
(pl)
|
2011-12-28 |
2017-12-29 |
Global Blood Therapeutics, Inc. |
Podstawione związki benzaldehydowe i sposoby ich zastosowania do zwiększania natlenienia tkanek
|
|
CA2874621A1
(en)
|
2012-05-22 |
2013-11-28 |
Genentech, Inc. |
N-substituted benzamides and their use in the treatment of pain
|
|
US10071957B2
(en)
|
2012-07-06 |
2018-09-11 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
ES2750640T3
(es)
*
|
2012-08-16 |
2020-03-26 |
Scripps Research Inst |
Ligandos opioides kappa novedosos
|
|
CN105263490B
(zh)
|
2013-03-14 |
2018-05-22 |
基因泰克公司 |
取代的三唑并吡啶及其使用方法
|
|
ES2663798T3
(es)
|
2013-03-14 |
2018-04-17 |
Daiichi Sankyo Company, Limited |
Fármaco para enfermedades respiratorias
|
|
JP6426694B2
(ja)
|
2013-03-15 |
2018-11-21 |
グローバル ブラッド セラピューティクス インコーポレイテッド |
ヘモグロビンの修飾のための化合物及びその使用
|
|
CA2898680A1
(en)
|
2013-03-15 |
2014-09-18 |
Genentech,Inc. |
Substituted benzoxazoles and methods of use thereof
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP2968299B1
(en)
|
2013-03-15 |
2021-01-20 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
BR112015021982B1
(pt)
|
2013-03-15 |
2022-12-13 |
Global Blood Therapeutics, Inc |
Compostos e seus usos para a modulação de hemoglobina
|
|
PE20151907A1
(es)
*
|
2013-03-15 |
2016-01-20 |
Global Blood Therapeutics Inc |
Compuestos y usos de estos para la modulacion de la hemoglobina
|
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
JP6383418B2
(ja)
|
2013-11-27 |
2018-08-29 |
ジェネンテック， インコーポレイテッド |
置換ベンズアミド及びその使用方法
|
|
US9975876B2
(en)
|
2013-12-09 |
2018-05-22 |
Merck Sharp & Dohme Corp. |
2-pyridyloxy-3-ester-4-ether orexin receptor antagonists
|
|
JP6045487B2
(ja)
*
|
2013-12-25 |
2016-12-14 |
シャープ株式会社 |
操作入力システム、電子機器、携帯端末、及び操作入力方法
|
|
AP2016009261A0
(en)
|
2014-02-07 |
2016-06-30 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
AU2015223049B2
(en)
*
|
2014-02-27 |
2019-03-21 |
Merck Patent Gmbh |
Heterocyclic compounds as NaV channel inhibitors and uses thereof
|
|
TW201623264A
(zh)
|
2014-03-29 |
2016-07-01 |
魯賓有限公司 |
作為電位閘控鈉通道調節劑之磺胺化合物
|
|
CN106715418A
(zh)
|
2014-07-07 |
2017-05-24 |
基因泰克公司 |
治疗化合物及其使用方法
|
|
WO2016021742A1
(en)
|
2014-08-07 |
2016-02-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds as ep4 receptor antagonists
|
|
MA42118A
(fr)
|
2015-05-22 |
2018-03-28 |
Genentech Inc |
Benzamides substitués et leurs méthodes d'utilisation
|
|
WO2017035271A1
(en)
|
2015-08-27 |
2017-03-02 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
TW201722938A
(zh)
|
2015-09-04 |
2017-07-01 |
魯賓有限公司 |
作為電位閘控鈉通道調節子之磺醯胺化合物
|
|
JP6987746B2
(ja)
|
2015-09-28 |
2022-01-05 |
ジェネンテック， インコーポレイテッド |
治療用化合物及びその使用方法
|
|
US10899732B2
(en)
|
2015-11-25 |
2021-01-26 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
PL3383392T3
(pl)
|
2015-12-04 |
2025-11-17 |
Global Blood Therapeutics, Inc. |
Schematy dawkowania dla 2-hydroksy-6-((2-(1-izopropylo-1H-pirazol-5-ilo)pirydyn3-ylo)metoksy)benzaldehydu
|
|
JP2019505508A
(ja)
|
2016-02-03 |
2019-02-28 |
シャンハイ ハイヤン ファーマシューティカル テクノロジー カンパニー リミテッドＳｈａｎｇｈａｉ Ｈａｉｙａｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ． |
複素環置換ｎ−スルホニルベンズアミド誘導体、その製造方法および医薬における使用
|
|
US10766858B2
(en)
|
2016-03-30 |
2020-09-08 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
TWI663160B
(zh)
|
2016-05-12 |
2019-06-21 |
全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
|
TW202332423A
(zh)
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
BR112019007763A2
(pt)
|
2016-10-17 |
2019-07-02 |
Genentech Inc |
composto de fórmula, composição farmacêutica, métodos para tratar uma doença ou condição, para tratar dores, para diminuir o fluxo de íons e para tratar prurido, uso de um composto e invenção
|
|
WO2018163077A1
(en)
|
2017-03-08 |
2018-09-13 |
Lupin Limited |
Indanyl compounds as voltage gated sodium channel modulators
|
|
EP3601273B1
(en)
|
2017-03-24 |
2021-12-01 |
Genentech, Inc. |
4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
|
|
AR114263A1
(es)
|
2018-02-26 |
2020-08-12 |
Genentech Inc |
Compuestos terapéuticos y métodos para utilizarlos
|
|
WO2019191702A1
(en)
|
2018-03-30 |
2019-10-03 |
F. Hoffmann-La Roche Ag |
Substituted hydro-pyrido-azines as sodium channel inhibitors
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|
|
EP3860975B1
(en)
|
2018-10-01 |
2023-10-18 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
|
CN109796402A
(zh)
*
|
2018-12-28 |
2019-05-24 |
京博农化科技有限公司 |
一种烟嘧磺隆中间体2-氯-n，n-二甲基烟酰胺的制备方法
|
|
KR102845511B1
(ko)
*
|
2019-02-08 |
2025-08-12 |
삼성디스플레이 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
US12240855B2
(en)
|
2019-03-06 |
2025-03-04 |
Daiichi Sankyo Company, Limited |
Pyrrolopyrazole derivative
|